Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T cell-inflamed gene expression profile is associated with favorable disease-specific survival in non-hypermutated microsatellite-stable colorectal cancer patients. | Cancer Med | 2023 | 36341526 | PubTator, text mining | PubMed |
| Extranodal T- and NK-cell lymphomas. | Virchows Arch | 2023 | 36336765 | PubTator, text mining | PubMed |
| Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials. | Haematologica | 2023 | 36325893 | PubTator, text mining | PubMed |
| Establishment, characterization and functional testing of two novel ex vivo extraskeletal myxoid chondrosarcoma (EMC) cell models. | Hum Cell | 2023 | 36316541 | PubTator, text mining | PubMed |
| A comprehensive atlas of epigenetic regulators reveals tissue-specific epigenetic regulation patterns. | Epigenetics | 2023 | 36305095 | PubTator, text mining | PubMed |
| A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition. | Cancer Discov | 2023 | 36264143 | PubTator, text mining | PubMed |
| Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes? | Turk J Gastroenterol | 2023 | 36262101 | PubTator, text mining | PubMed |
| Transformation of FL into DLBCL with a PMBL gene expression signature. | Blood Adv | 2023 | 36240289 | PubTator, text mining | PubMed |
| Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies. | Cancer Sci | 2023 | 36178064 | PubTator, text mining | PubMed |
| Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms. | Blood Adv | 2023 | 36170795 | PubTator, text mining | PubMed |
| Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories. | Brain Pathol | 2023 | 36167400 | PubTator, text mining | PubMed |
| DNA damage accumulation and repair defects in FLT3-ITD acute myeloid leukemia: Implications for clonal evolution and disease progression. | Hematol Oncol | 2023 | 36131612 | PubTator, text mining | PubMed |
| Genomic landscape of multiple Bowen's disease using whole-exome sequencing. | J Dermatol | 2023 | 36117467 | PubTator, text mining | PubMed |
| First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma. | Blood Adv | 2023 | 36095303 | PubTator, text mining | PubMed |
| Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma. | Cancer Sci | 2023 | 36086920 | PubTator, text mining | PubMed |
| The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM. | Blood | 2023 | 35984902 | PubTator, text mining | PubMed |
| Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. | Gut | 2023 | 35944927 | PubTator, text mining | PubMed |
| Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. | J Hepatobiliary Pancreat Sci | 2023 | 35918906 | PubTator, text mining | PubMed |
| Analysis of rare driving events in pediatric acute myeloid leukemia. | Haematologica | 2023 | 35899387 | PubTator, text mining | PubMed |
| Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association. | Blood Adv | 2023 | 35882439 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=44